BridgeMD
New treatment option for Early Gastric Cancer
Official title Magnetic Guided Counetrtraction During Endoscopic Submucosal Dissection
ClinicalTrials.gov ID: NCT06962293
What this study is testing
- What it's testing
- Endoscopic submucosal dissection (ESD) is a technique that allows curative treatment of early gastrointestinal neoplasia with organ preservation. However, it is a technically demanding procedure.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Patient with superficial gastric or colorectal lesions, scheduled for endoscopic submucosal dissection (ESD).
You likely can't join if
- Patient who refused to participate
- Other cases deemed by the examining physician as unsuitable for safe treatment The robotic magnetic countertraction system consist of a strong...
- Patient who had a cardiac pacemaker.
- Patient who had any metallic implant or device, such as drug pump, stent, etc.
- Patient who has or had any metal fragments in eye or any other part of body, or had ever worked with metal.
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.